230 related articles for article (PubMed ID: 37253062)
1. Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein.
Grunst MW; Ladd RA; Clark NM; Gil HM; Klenchin VA; Mason R; Franchini G; Roederer M; Evans DT
PLoS Pathog; 2023 May; 19(5):e1011407. PubMed ID: 37253062
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies.
von Bredow B; Arias JF; Heyer LN; Moldt B; Le K; Robinson JE; Zolla-Pazner S; Burton DR; Evans DT
J Virol; 2016 Jul; 90(13):6127-6139. PubMed ID: 27122574
[TBL] [Abstract][Full Text] [Related]
3. Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIV
von Bredow B; Andrabi R; Grunst M; Grandea AG; Le K; Song G; Berndsen ZT; Porter K; Pallesen J; Ward AB; Burton DR; Evans DT
mBio; 2019 Jul; 10(4):. PubMed ID: 31266872
[TBL] [Abstract][Full Text] [Related]
4. A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays.
Alpert MD; Heyer LN; Williams DE; Harvey JD; Greenough T; Allhorn M; Evans DT
J Virol; 2012 Nov; 86(22):12039-52. PubMed ID: 22933282
[TBL] [Abstract][Full Text] [Related]
5. Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.
Kilgore KM; Murphy MK; Burton SL; Wetzel KS; Smith SA; Xiao P; Reddy S; Francella N; Sodora DL; Silvestri G; Cole KS; Villinger F; Robinson JE; Pulendran B; Hunter E; Collman RG; Amara RR; Derdeyn CA
J Virol; 2015 Aug; 89(16):8130-51. PubMed ID: 26018167
[TBL] [Abstract][Full Text] [Related]
6. Short Communication: Small-Molecule CD4 Mimetics Sensitize HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity by Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Nonhuman Primates.
Ding S; Verly MM; Princiotto A; Melillo B; Moody AM; Bradley T; Easterhoff D; Roger M; Hahn BH; Madani N; Smith AB; Haynes BF; Sodroski J; Finzi A
AIDS Res Hum Retroviruses; 2017 May; 33(5):428-431. PubMed ID: 27846736
[TBL] [Abstract][Full Text] [Related]
7. Across Functional Boundaries: Making Nonneutralizing Antibodies To Neutralize HIV-1 and Mediate Fc-Mediated Effector Killing of Infected Cells.
Richard J; Nguyen DN; Tolbert WD; Gasser R; Ding S; Vézina D; Yu Gong S; Prévost J; Gendron-Lepage G; Medjahed H; Gottumukkala S; Finzi A; Pazgier M
mBio; 2021 Oct; 12(5):e0140521. PubMed ID: 34579568
[TBL] [Abstract][Full Text] [Related]
8. Simian Immunodeficiency Virus SIVmac239, but Not SIVmac316, Binds and Utilizes Human CD4 More Efficiently than Rhesus CD4.
Fellinger CH; Gardner MR; Bailey CC; Farzan M
J Virol; 2017 Sep; 91(18):. PubMed ID: 28679752
[TBL] [Abstract][Full Text] [Related]
9. Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys.
Nguyen QN; Martinez DR; Himes JE; Whitney Edwards R; Han Q; Kumar A; Mangan R; Nicely NI; Xie G; Vandergrift N; Shen X; Pollara J; Permar SR
Retrovirology; 2018 Mar; 15(1):24. PubMed ID: 29523166
[TBL] [Abstract][Full Text] [Related]
10. The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals.
Veillette M; Coutu M; Richard J; Batraville LA; Dagher O; Bernard N; Tremblay C; Kaufmann DE; Roger M; Finzi A
J Virol; 2015 Jan; 89(1):545-51. PubMed ID: 25339767
[TBL] [Abstract][Full Text] [Related]
11. Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity.
Veillette M; Désormeaux A; Medjahed H; Gharsallah NE; Coutu M; Baalwa J; Guan Y; Lewis G; Ferrari G; Hahn BH; Haynes BF; Robinson JE; Kaufmann DE; Bonsignori M; Sodroski J; Finzi A
J Virol; 2014 Mar; 88(5):2633-44. PubMed ID: 24352444
[TBL] [Abstract][Full Text] [Related]
12. Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1.
Gohain N; Tolbert WD; Acharya P; Yu L; Liu T; Zhao P; Orlandi C; Visciano ML; Kamin-Lewis R; Sajadi MM; Martin L; Robinson JE; Kwong PD; DeVico AL; Ray K; Lewis GK; Pazgier M
J Virol; 2015 Sep; 89(17):8840-54. PubMed ID: 26085162
[TBL] [Abstract][Full Text] [Related]
13. Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challenge.
Grunst MW; Gil HM; Grandea AG; Snow BJ; Andrabi R; Nedellec R; Burton I; Clark NM; Janaka SK; Keles NK; Moriarty RV; Weiler AM; Capuano S; Fennessey CM; Friedrich TC; O'Connor SL; O'Connor DH; Broman AT; Keele BF; Lifson JD; Hangartner L; Burton DR; Evans DT
PLoS Pathog; 2024 Jan; 20(1):e1011819. PubMed ID: 38252675
[TBL] [Abstract][Full Text] [Related]
14. Truncating the gp41 Cytoplasmic Tail of Simian Immunodeficiency Virus Decreases Sensitivity to Neutralizing Antibodies without Increasing the Envelope Content of Virions.
White E; Wu F; Chertova E; Bess J; Roser JD; Lifson JD; Hirsch VM
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142124
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stock.
Lopker M; Easlick J; Sterrett S; Decker JM; Barbian H; Learn G; Keele BF; Robinson JE; Li H; Hahn BH; Shaw GM; Bar KJ
J Virol; 2013 May; 87(10):5477-92. PubMed ID: 23468494
[TBL] [Abstract][Full Text] [Related]
16. Potent
Bardhi A; Wu Y; Chen W; Li W; Zhu Z; Zheng JH; Wong H; Jeng E; Jones J; Ochsenbauer C; Kappes JC; Dimitrov DS; Ying T; Goldstein H
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794022
[TBL] [Abstract][Full Text] [Related]
17. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.
Dupuy FP; Kant S; Barbé A; Routy JP; Bruneau J; Lebouché B; Tremblay C; Pazgier M; Finzi A; Bernard NF
mBio; 2019 Dec; 10(6):. PubMed ID: 31848282
[TBL] [Abstract][Full Text] [Related]
18. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
[TBL] [Abstract][Full Text] [Related]
19. Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies.
Mielke D; Stanfield-Oakley S; Borate B; Fisher LH; Faircloth K; Tuyishime M; Greene K; Gao H; Williamson C; Morris L; Ochsenbauer C; Tomaras G; Haynes BF; Montefiori D; Pollara J; deCamp AC; Ferrari G
J Virol; 2022 Jan; 96(2):e0164321. PubMed ID: 34730393
[TBL] [Abstract][Full Text] [Related]
20. Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins.
Richard J; Pacheco B; Gohain N; Veillette M; Ding S; Alsahafi N; Tolbert WD; Prévost J; Chapleau JP; Coutu M; Jia M; Brassard N; Park J; Courter JR; Melillo B; Martin L; Tremblay C; Hahn BH; Kaufmann DE; Wu X; Smith AB; Sodroski J; Pazgier M; Finzi A
EBioMedicine; 2016 Oct; 12():208-218. PubMed ID: 27633463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
